Centessa Pharmaceuticals plc
CNTANASDAQHealthcareBiotechnology
As of Jun 29, 2026 close
- Market cap
- $6.22B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- 93.83%
- 52-week range
- $17.05$40.56
- Volume (live)
- -
- Avg. volume (3M)
- -
CNTA was delisted on Oct 24, 2026. Data shown is historical and no longer updated.
Centessa Pharmaceuticals (CNTA) Stock Price & Financial Analysis
Centessa Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $40.50 - $40.50 |
|---|---|
| 52-Week High | $40.56 |
| 52-Week Low | $17.05 |
| Open | $40.50 |
| 50-Day MA | $39.76 |
|---|---|
| 200-Day MA | $29.63 |
| 1-Year Change | +67.77% |
| Market Cap | 6.22B |
|---|---|
| Shares Outstanding | 153.55M |
| Price to Book (P/B) | 12.76 |
| EV/EBITDA | -26.43 |
| Annual Dividend | $38.00 |
|---|---|
| Dividend Yield | 93.83% |
| Last Dividend Ex-Date | Jun 24, 2026 |
Source: Market prices and company fundamentals. Data as of Jun 29, 2026. Data sources and methodology
Centessa Pharmaceuticals at a Glance
As of the Jun 29, 2026 close, Centessa Pharmaceuticals (CNTA) has a market capitalization of $6.22B. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $62.43M in cash and securities against $110.44M of debt, a net debt position of $48.01M.
Centessa Pharmaceuticals pays dividends totaling $38.00 per share a year, a 93.83% yield at the Jun 29, 2026 close.
The share price is up 67.8% over the past year. At $40.50 (the Jun 29, 2026 close) it sits near the top of its 52-week range of $17.05 to $40.56, above its 200-day moving average of $29.63.
Frequently Asked Questions About Centessa Pharmaceuticals
What is the current stock price for CNTA?
As of the Jun 29, 2026 close, CNTA stock trades at $40.50. The 52-week range is $17.05–$40.56, with a day range of $40.50–$40.50.
What is the P/E ratio for CNTA?
The P/E ratio (Price-to-Earnings) for CNTA is shown in the Key Statistics section. This valuation metric helps compare Centessa Pharmaceuticals plc to industry peers.
Does CNTA pay dividends?
Yes, Centessa Pharmaceuticals pays a 93.83% annual dividend yield as of the Jun 29, 2026 close ($38.00 per share a year). The most recent ex-dividend date was June 24, 2026.
What do analysts recommend for CNTA?
Analyst ratings and recommendations for CNTA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CNTA?
As of the Jun 29, 2026 close, Centessa Pharmaceuticals's market capitalization is $6.22B, classifying it as a mid-cap company. Centessa Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.